Folia Pharmacologica Japonica Previous Issues

     


Full-Text Online (FREE)
Vol. 139  
No5 - May œReview: Pre- and Post-Approval Drug Development i10ji11ji12j
No4 - April œReviews: Environmental Insults That Precipitate Psychiatric Disorders on Multiple Life Stages and the Implications for Pharmaceutical Development
œReview: Pre- and Post-Approval Drug Development (9)
No3 - March œReview: Pre- and Post-Approval Drug Development (7) (8)
No2 - February

 œReviews: Dysfunction of Transportsome in Diseases and Its Possibility as Therapeutic Targets
No1 - July

 œReviews: Hydrogen Sulfide as a Signal Molecule as well as a Cytoprotectant
œReview: Pre- and Post-Approval Drug Development (6)
Vol.138  
No6 - Decemer
 œReviews: New Experimental Approaches for Studying Ion Channels and Transporters as Targets for Drug Discovery and Novel screening Methods
œReview: Pre- and Post-Approval Drug Development (3), (4), (5)
No5 - Novemer
 œReviews: Inflammation in Cardiovascular Diseases
œReview: Pre- and Post-Approval Drug Development (1), (2)
No4 - October
 œReviews: Current status and future scope of strategies for treating acute lung injury
No3 - September
 œReviews: Alternative approaches to animal experiments in Asia
No2 - August
 œReview: Molecular mechanisms of H+ and Cl− secretion in gastric parietal cells
œReview: Drug Discovery(5) Translational Research (24) (25) (26)
No1 - July
 œSpecial Lecture: Molecular targeted drugs against ALK fusions
œReviews: Enzymes involved in the degradation of N-acylethanolamines functioning as lipid mediators
œReview: Drug Discovery(5) Translational Research (22) (23)
Vol.137  
No6 - June
 œReview: Drug Discovery(5) Translational Research (20) (21)
No5 - May
 œReviews: Ion dynamics in intracellular organelles as a new target of drug development and its involvement in diseases
œReview: Drug Discovery(5) Translational Research‡R
No4 - Apr
 œReview: Molecular mechanisms of central feeding regulation
œReview: Drug Discovery(5) Translational Research‡Q
No3 - Mar
 œReviews: New Therapeutic Approach by Combination Chronopharmacology and Chrononeutrition
œReview: Drug Discovery(5) Translational Research‡O‡P
No2 - Feb
œReview: Pharmacology for Pharmaceutical Care
œReview: Drug Discovery(5) Translational Research‡L‡M‡N
No1 - Jan
œReviews: Kampo Pharmacology: Basic of Evidence-Based Herbal Medicine
œReview: Drug Discovery(5) Translational Research‡K
Vol. 136  
No6 - Dec
œReview: Recent Achievements Available for the Treatment of Hyperuricemia and Gout
œReview: Drug Discovery(5) Translational Research‡I‡J
No5 - Nov
œReview: Research and Development Strategy of Agents for the Treatment of Metabolic Diseases
œReview: Drug Discovery(5) Translational Research‡G‡H
No4 - Oct
œReviews: Research and Development Strategy of Agents for Cancer
œReview: Drug Discovery(5) Translational Research‡F
No3 - Sep
œReview: Research and Development Strategy of Agents for the Treatment of Psychiatric Disorders
œReview: Drug Discovery(5) Translational Research‡E
No2 - Aug
œReview: Research and Development Strategy of Agents for Cardiovascular Disease
œReview: Drug Discovery(5) Translational Research‡D
No1 - Jul
œReview: Research on and Development Strategy for Agents to Treat Alzheimer's Disease
œReview: Drug Discovery(5) Translational Research‡B‡C
Vol. 135  
No6 - Jun
œAward Lecture
œReview: Drug Discovery(5) Translational Research‡A
No5 - May
œReview: Drug Discovery(5) Translational Research‡@
No4 - Apr
œReview: Recent Progress in Ocular Pharmacology
No3 - Mar
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Other‡B‡C
No2 - Feb
œReview: Pharmacological and Non-Pharmacological Approaches to Atrial Fibrillation: Current Status and New Perspectives
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Excretion‡B
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Other‡@‡A

No1 - Jan
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Excretion‡@‡A
   
Vol. 134  
No6 - Dec
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Metabolism ‡E‡F‡G
No5 - Nov
œReview: Novel Function of G Protein-Coupled Receptors
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Metabolism ‡C‡D
No4 - Oct
œReview: Apoptosis-Related Molecules as a Therapeutic Target for Different Diseases
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Metabolism ‡B
No3 - Sep
œReview: New Features and Pathophysiological Roles of TRP Channel Proteins
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Metabolism ‡@‡A
No2 - Aug
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Distribution ‡@‡A
No‚P - Jul
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Absorption ‡C
Vol. 133 (2009)
No6 - Jun
œReview: Statistics in Pharmacology
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Absorption ‡B
No5 - May
œAward Lecture
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Absorption ‡@‡A
No4 - Apr
œReview: Pathophysiological Studies and Target Validation of Lower Digestive Tract
œReview: Drug Discovery(4) DMPK Assessments for Human Drug Development: Preface
No3 - Mar
œReview: Recent Achievements Available for the Treatment of Vascular Diseases
œReview: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development‡L
No2 - Feb
œReview: Curatives (33) Molecular Target Drugs 4-2
œReview: Curatives (34) Anti-Androgenetic Alopecia
œReview: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development ‡J‡K
No1 - Jan
œReview: Pharmacological Evaluation of the Risk of Drug-Induced Long QT Syndrome
œReview: Curatives (33) Molecular Target Drugs 4-1
Vol. 132 (2008)
No6 - Dec
œReview: Curatives (32) Molecular Target Drugs 3-2
œReview: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development ‡H‡I
No5 - Nov
œReview: Pharmacology of Kampo Medicine: Basic Evidence to Clinical Applications
œReview: Curatives (31) Anti-Parasitic Drugs and Therapy for Tropical Diseases
œReview: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development ‡G
No4 - Oct
œReview: Curatives (30) Molecular Target Drugs 3-1
œReview: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development ‡F
No3 - Sep
œReview: Pharmacological Approach in Health Foods: From Basic Science Research to Venture Business
œReview: Curatives (29) Molecular Target Drugs-2
No2 - Aug
œReview: Curatives (27) Drugs for the Treatment of Kidney Disease
œReview: Curatives (28) Molecular Target Drugs-1
No1 - Jul
œReviews: Invitation to Chemical Biology
œReviews: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development‡E
Vol. 131 (2008)
No6 - Jun
œReview: Basic and Clinical Understanding of the Treatment of Chronic Cough
œReview: Curatives (26) Antiarrhythmic Drugs
œReviews: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development‡D
No5 - May
œReviews: gBench to Bedsideh Strategies for Alzheimer's Disease: What's to Be Solved Now?
œReviews: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development‡C
No4 - Apr
œReviews: Pharmacological Approach to gMibyouh
œReview: Curatives (25) Anti-Parkinson's Disease Agents
œReviews: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development‡B
No3 - Mar
œMini-Reviews: Basic and Clinical Pharmacology of the Renin-Angiotensin System: From Bench to Bedside
œReview: Curatives (24) Antimigraine Agents
œReviews: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development‡A
No2 - Feb
œReviews: Significance of Vascular Endothelial Cell Disorders in Life-Style-Related Diseases and Emergency Diseases
œReview: Curatives (23) Anti-Asthmatic Agents
No1 - Jan
œReviews: Curatives(22) Age-Related Macular Degeneration
œReviews: Drug Discovery (3-3) Nonclinical Safety Assessments for Human Drug Development‡@
Vol. 130 (2007)
No6 - Dec
œReviews: New Aspects of Neurotransmitter Transporter Research
œReviews: Curatives(21) Alzheimer's Disease
œReviews: Drug Discovery (3-2) Nonclinical Safety Assessments for Human Drug Development‡B‡C
No5 - Nov
œReviews: Actin Cytoskeleton in Nerve Cells
œReviews: Curatives(20) Arteriosclerosis
œReviews: Drug Discovery (3-2) Nonclinical Safety Assessments for Human Drug Development‡@‡A
No4 - Oct
œReviews: Heme Metabolism as Possible Targets for Future Drug Development
œReviews: Curatives(19) Antibiotics
œReviews: Drug Discovery (3-1) Nonclinical Safety Assessments for Human Drug Development‡G
No3 - Sep
œReviews: Curatives(18) Anti-osteoporotic Agents
œReviews: Drug Discovery (3-1) Nonclinical Safety Assessments for Human Drug Development‡E‡F
No2 - Aug
œReviews: A Primer of Behavioral Pharmacology
œReviews: Curatives(17) Antiviral agents
œReviews: Drug Discovery (3-1) Nonclinical Safety Assessments for Human Drug Development‡C‡D
No1 - Jul
œReviews: Current Progress for GPCR Studies
œReviews: Curatives(16) Antifungal agents
œReviews: Drug Discovery (3-1) Nonclinical Safety Assessments for Human Drug Development‡A‡B
Vol. 129  
No6 - Jun
œReviews: Sleep and Sleep Disorders
œReviews: Drug Discovery (3-1) Nonclinical Safety Assessments for Human Drug Development‡@
No5 - May
œReviews: The Techniques for Production of Mutant Mice and Related Matters
œReviews: Curatives(15) Dysurea
No4 - Apr
œReviews: Intracellular Signal Transduction in Relation to Cardiovascular Diseases
œReviews: Curatives(14) Dyslipidemic Agents
œReviews: Drug Discovery (2) Lead Compounds
No3 - Mar
œReviews: Molecular Mechanism and Therapeutic Strategy of Vascular Diseases
œReviews: Curatives(13) Rheumatoid Arthritis
œReviews: Drug Discovery (1) Drug Targets[5] @œReviews: Drug Discovery (2) Lead Compounds
No2 - Feb
œReviews: Stress and Life
œReviews: Curatives(12) Epilepsy
œReviews: Drug Discovery (1) Drug Targets[3],[4]
No1 - Jan
œReviews: Guidelines for Animal Experiments
œReviews: Curatives(11) Insomnia
œReviews: Drug Discovery (1) Drug Targets[1],[2]
   
Vol. 128 (2006)
No6 - Dec
œReviews: Patch Clamp
œReviews: Curatives(10) Atopic Dermatitis

No5 - Nov
œReviews: Pros and Cons of In Vitro Studies for Evaluation of Pharmacological Effects
œReviews: Curatives(9) Pain

No4 - Oct
œReviews: Strategies for Treatment of Life Style-Related Diseases
œReviews: Curatives(8) Glaucoma
No3 - Sep
œReviews: From Signaling Pathways to Pharmacogenomics Network
œReviews: Curatives(7) Schizophrenia
No2 - Aug
œReviews: Frontiers of Gastrointestinal Disease Research
œReviews: Curatives(6) Irritable bowel syndrome
No1 - Jul
œReviews: Stress and Psychiatric Disorders: Stress Changes the Brain
œReviews: Curatives(5) Diabetes
Vol. 127 (2006)
No6 - Jun
œReviews: Pharmacology of Adverse Drug Reaction
œReviews: Curatives(4) Acute Stroke
No5 - May
œReviews: Tumor-specificity and Apoptosis
œReviews: Curatives(3) Hypertension
No4 - Apr
œReviews: Secretory Function and Dysfunction of the Salivary Gland
œReviews: Curatives(2) COPD
No3 - Mar
œReviews: New Approaches for Pain Studies
œReviews: Curatives(1) Depression
No2 - Feb
œReviews: Progress in Study of Central Feeding Regulation by Neuropeptide Y (NPY)
œTechnical Note: Evaluation of drugs for the treatment of atopic dermatitis in mice
No.1 - Jan
œReviews:Regulation of Signaling and Its Related Disease in the CNS
Vol. 126 (2005)
No.6 - Dec
œReviews: New Targets and Strategies in Heart Failure
œTechnical Note: Visualizing exocytosis of insulin granules with total internal reflection fluorescence microscopy
No.5 - Nov
œReviews: Toward Ion Channel Drug Discovery: Potential Approach and New Technology
œTechnical Note: Molecular imaging techniques for research on brain function using PET
No.4 - Oct
œReviews: Molecular and Cellular responses of Cardiovascular System Induced by Mechanical and Oxydative Stresses
No.3 - Sep
œReviews: Stress and Brain
No.2 - Aug
œReviews: Stress and Anxiety Disorder: Evaluation of Animal Behaviors in Preclinical Studies
œSeries: Pharmacology in the Post-Genome Sequencing EraœPharmacoinformatics and pharmacogenomics//Systembiology
No.1 - Jul
œReviews: Evaluation Method and Strategy for Drug Dependence Research
œSeries: Pharmacology in the Post-Genome Sequencing EraœGenome network//Tailor-made medicine
Vol. 125 (2005)
No.6 - Jun
œReviews: Development of Alternative Animal Experiments in Pharmacology
œSeries: Pharmacology in the Post-Genome Sequencing Eraœ
No.5 - May
œReviews: The Latest Frontiers in the Treatment of Allergic Inflammation -Basic Analysis and Clinical Research-œ
œAward Lecture: Molecular mechanism of vascular dysfunction in the insulin-resistant stateœ
No.4 - Apr
œReviews: Frontiers in Drug Transporter Researchœ
œSeries: Pharmacology in the Post-Genome Sequencing Eraœ
No.3 - Mar

œReviews: Neuronal Insulin Signalings and Their Functional Rolesœ
œSeries: Pharmacology in the Post-Genome Sequencing Eraœ
No.2 - Feb
œReviews: New Perspectives for Studies on Emotional Experience and Expression: From Animals to Humans
No.1 - Jan

œReviews: Molecular Pharmacology of Emotion - Basis for Improvement of QOL
       
Vol. 123 (2004) Vol. 124 (2004)
No.6 - Jun
 		Reviews: ATP Transport System: Update
 No.6 - Dec Reviews: Topics on the Mechanism of ER Stress Involvement in the Regulation of Brain Cell Death
No.5 - May
 		  No.5 - Nov Reviews: Novel Functions of Calmodulin-Dependent Signal Transduction and Drug Development
No.4 - Apr
 Reviews: PACAP/VIP Signaling System: a Novel Target for New Drugs
 No.4 - Oct Reviews: New Expansion of Sensation Pharmacology
No.3 - Mar
Reviews: Regulatory Mechanism of Motility of the Gastrointestinal Tract
 No.3 - Sep Reviews: Update on the Therapeutic Drugs for Alzheimer's Disease
No.2 - Feb
 Reviews: Molecular Basis of Heart Failure and its Treatments No.2 - Aug
 		 Reviews: Further Pharmacological Objectives in the Renin-Angiotensin System
No.1 - Jan Reviews: Physiology and Pharmacology of Prostaglandin D2 and Related Molecules
 No.1 - July  
       
Vol. 121 (2003) Vol. 122 (2003)
No.6 - Jun Reviews: Pharmacological Evaluation of the Risk of Drug-Induced Long QT Syndrome
 No.6 - Dec Reviews: Tyrosine Kinase as a Molecular Target for Drugs
No.5 - May Reviews: Current Progress in Studies on Lower Urinary Tract Function: From the Standpoint of Basic and Clinical Medicine No.5 - Nov Reviews: Receptor and Channel Gene Manipulation in Disease Models
No.4 - Apr Reviews: Recent Advances in Ca2+ Channel Research No.4 - Oct Reviews: Roles of PPARƒΑ: From Physiological Functions to Drug Development
No.3 - Mar   No.3 - Sep Reviews: Contribution of Pharmacology and Physiology to QOL
No.2 - Feb@   No.2 - Aug  
No.1 - Jan Reviews: Pharmacological Aspects of Heat Shock Proteins Relevant to Drug Development
 No.1 - July Reviews: Update and Perspectives of Studies on Proteases and Diseases
       
Vol. 119 (2002) Vol. 120 (2002)
No.6 - Jun   No.6 - Dec  
No.5 - May   No.5 - Nov@ Reviews: Applications of Gene Knockout Mice for Drug Development
No.4 - Apr Reviews Genetically Engineered Mice as a Tool for Pharmacological Studies No.4 - Oct  
No.3 - Mar   No.3 - Sep Reviews: Pharmacology as Translational Research: Strategies and Problems

No.2 - Feb   No.2 - Aug  
No.1 - Jan ReviewsFPathophysiological Roles of NO \Progress Towards the Development of Novel Medicines\ No.1 - July@ Reviews: Physiological Function of the Mucosa and Potential Prologues of Its Dysfunction and Pathological Implications
       
Vol. 117 (2001) Vol. 118 (2001)
No. 6 - Jun   No. 6 - Dec  
No. 5 - May   No. 5 - Nov Reviews: The Concept of Producing Anti-obesity Drugs: Its Past, Present and Future Prospects
No. 4 - Apr Reviews: The Prostanoid Receptors: Molecular Approaches to Drug Development
 No. 4 - Oct  
No. 3 - Mar   No. 3 - Sep Reviews: Towards Understanding Mechanisms of Drug Action and Functions of the Body on the Molecular Level
No. 2 - Feb   No. 2 - Aug  
No. 1 - Jan Reviews: New Developments in Drug Dependence Studies No. 1 - July Reviews: Frontiers in Histamine Research in the Peripheral Tissue
       
Vol. 115 (2000) Vol. 116 (2000)
No. 6 - Jun   No. 6 - Dec  
No. 5 - May   No. 5 - Nov Reviews: Research and Development of Novel Anti-thrombotic Agents
No. 4 - Apr Reviews: Intercommunication Between Cytokine- and Neurotransmitter-Systems No. 4 - Oct  
No. 3 - Mar   No. 3 - Sep Reviews: Pharmacology - the Bridge to the 21st Century -
No. 2 - Feb   No. 2 - Aug  
No. 1 - Jan Reviews: Anxiety and Stress No. 1 - July Reviews: The Role of Biostatistics in Pharmacological Studies
       
Vol. 113 (1999) Vol. 114 (1999)
No. 6 - June   No. 6 - Dec  
No. 5 - May   No. 5 - Nov Reviews: Stress and Redox Regulation
No. 4 - Apr Reviews: Pharmacological Perspectives on Microcirculation No. 4 - Oct  
No. 3 - Mar   No. 3 - Sep
 		 Reviews: A New Century of Pharmacology Is Coming
No. 2 - Feb   No. 2 - Aug  
No. 1 - Jan Reviews: The Role of Pharmacology in the Globalization of Drug Development No. 1 - July Reviews: Pharmacological Effects of sigma-Receptor Ligands
       
Vol. 111 (1998) Vol. 112 (1998)
No. 6 - June   No. 6 - Dec  
No. 5 - May   No. 5 - Nov  
No. 4 - Apr Reviews: Pathogenetic Mechanisms of Bronchial Asthma and Airway Hyperresponsiveness: A Pharmacological View
 No. 4 - Oct  
No. 3 - Mar   No. 3 - Sep Reviews: Recent Advances in Research on Bioactive Endogenous Substances
No. 2 - Feb   No. 2 - Aug  
No. 1 - Jan Reviews: Molecular Pathopharmacology of Cellular Responses to Brain Ischemia No. 1 - July Reviews: P450: Genetic Polymorphism and Pharmacological Function of Metabolites of Endogenous Compounds
       
    Vol. 110 (1997)
    No. 6 - Dec Reviews: Statistical Analysis of Pharmacological Data:
    No. 5 - Nov 70th Anniversary of the establishment
    No. 4 - Oct  
    No. 3 - Sep Clarification of Signal Transduction via Drug Receptor and Drug Development
    No. 2 - Aug  
    No. 1 - July  
Editorial Office:
The Japanese Pharmacological Society,
Kantohya bldg, Gokomachi-Ebisugawa,
Nakagyo-ku, Kyoto 604-0982, Japan
TEL: +81-075-252-4641
FAX: +81-075-252-4618
E-mail: journal@pharmacol.or.jp
Copyright The Japanese Pharmacological Society
‚±‚Μƒy[ƒW‚̐ζ“ͺ‚Φ–ί‚ι Copyright(C) The Japanese Pharmacological Society All Rights Reserved.